Reuters logo
BRIEF-Cellectar Biosciences reports pricing of $8,000,000 public offering
2016年11月23日 / 下午1点42分 / 1 年前

BRIEF-Cellectar Biosciences reports pricing of $8,000,000 public offering

Nov 23 (Reuters) - Cellectar Biosciences Inc :

* Cellectar Biosciences Inc- pricing shares of its preferred stock convertible into 66,667 shares of common stock at price of $1.50 per share

* Cellectar Biosciences Inc- pricing for gross proceeds of approximately $8.0 million

* Cellectar Biosciences announces pricing of $8,000,000 public offering Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below